Xcout Intel
Tacalyx
Tacalyx is a life sciences and biotechnology company headquartered in Berlin, Germany, focused on developing lead TACA-targeted therapeutics.
Subscribe to see Tacalyx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tacalyx at a glance
Tacalyx is a drug discovery company headquartered in Germany. It has raised at least $22.7M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $15M in June 2024. Xcout tracks 11 named people at Tacalyx, including Jean Engela (CEO).
Tacalyx leadership
- Jean EngelaCEO
- Dr. Klaus SchollmeierChairman of the Board
- Peter SondermannCSO & Co-founder
- Detlev MennerichBoehringer Ingelheim Venture Fund (BIVF)
- Dr. Frank HenselHigh-Tech Gründerfonds
- Dr. Peter NeubeckKurma Partners
5 more named people on record for Tacalyx, with roles, board committees and tenure — see the full roster →
Tacalyx funding rounds
At least $22.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $15M | 4 named | |
| Seed | $7.7M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Tacalyx competitors
A few of Tacalyx's closest competitors — see the full list of competitors and alternatives →
Ariceum Therapeutics is a radiopharmaceutical company headquartered in Berlin, Germany, with operations across several countries, focused on the development of novel medical treatments.
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Smartbax is a biotechnology startup founded in Munich, Germany, in 2021, dedicated to developing innovative next-generation antibiotics to combat the rising threat of multidrug-resistant bacteria.
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
Get Tacalyx's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tacalyx in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access